Why did this happen? These T-Cells target and destroy any abnormal cells, including cancer cells. The FDA is expected to review Bristol Myers Squibbs Opdivo for additional indications and Zeposia for treating ulcerative colitis. After the multiple myeloma CAR-T therapy approval, eyes will now be on the FDAs decision regarding Opdivos use for additional indications, as well as Zeposia in ulcerative colitis. That said, the recent approval marks the only approved CAR-T therapy for the treatment of multiple myeloma.
Now, Eyes will be on the NAFTA decision regarding Opdivoos use for destroying carcinomas.
( z0 eye :time ( z1 now ) :topic ( z2 decide :ARG0 ( z3 treaty :name ( z4 name :op "NAFTA" ) ) :ARG3 ( z5 use :ARG1 ( z6 product :name ( z7 name :op "Opdivoos" ) ) :ARG2 ( z8 destroy :ARG1 ( z9 cancer ) ) ) ) )
(z0 / eye
    :time (z1 / now)
    :topic (z2 / decide-01
               :ARG0 (z3 / treaty
                         :name (z4 / name
                                   :op1 "NAFTA"))
               :ARG3 (z5 / use-01
                         :ARG1 (z6 / product
                                   :name (z7 / name
                                             :op1 "Opdivoos"))
                         :ARG2 (z8 / destroy-01
                                   :ARG1 (z9 / cancer)))))
Now , Eyes will be on the NAFTA decision regarding Opdivoos use for destroying carcinomas .
z0 :time z1
z3 :name z4
z4 :op1 0
z2 :ARG0 z3
z0 :topic z2
z6 :name z7
z7 :op1 1
z5 :ARG1 z6
z2 :ARG3 z5
z5 :ARG2 z8
z8 :ARG1 z9